BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29132815)

  • 1. Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis.
    Lavoie S; Jack BN; Griffiths O; Ando A; Amminger P; Couroupis A; Jago A; Markulev C; McGorry PD; Nelson B; Polari A; Yuen HP; Whitford TJ
    Schizophr Res; 2018 Jan; 191():95-100. PubMed ID: 29132815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auditory mismatch negativity and P3a in response to duration and frequency changes in the early stages of psychosis.
    Nagai T; Tada M; Kirihara K; Yahata N; Hashimoto R; Araki T; Kasai K
    Schizophr Res; 2013 Nov; 150(2-3):547-54. PubMed ID: 24012461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration and frequency mismatch negativity shows no progressive reduction in early stages of psychosis.
    Koshiyama D; Kirihara K; Tada M; Nagai T; Koike S; Suga M; Araki T; Kasai K
    Schizophr Res; 2017 Dec; 190():32-38. PubMed ID: 28314681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between mismatch negativity and global functioning is specific to duration deviance in early stages of psychosis.
    Koshiyama D; Kirihara K; Tada M; Nagai T; Fujioka M; Koike S; Suga M; Araki T; Kasai K
    Schizophr Res; 2018 May; 195():378-384. PubMed ID: 28986006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis.
    Atkinson RJ; Michie PT; Schall U
    Biol Psychiatry; 2012 Jan; 71(2):98-104. PubMed ID: 22000060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mismatch Negativity Predicts Remission and Neurocognitive Function in Individuals at Ultra-High Risk for Psychosis.
    Fujioka M; Kirihara K; Koshiyama D; Tada M; Nagai T; Usui K; Morita S; Kawakami S; Morita K; Satomura Y; Koike S; Suga M; Araki T; Kasai K
    Front Psychiatry; 2020; 11():770. PubMed ID: 32848939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of early cortical processing and reading ability to functional status in individuals at clinical high risk for psychosis.
    Carrión RE; Cornblatt BA; McLaughlin D; Chang J; Auther AM; Olsen RH; Javitt DC
    Schizophr Res; 2015 May; 164(1-3):1-7. PubMed ID: 25728833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auditory event-related potential of subjects with suspected pre-psychotic state and first-episode psychosis.
    Hsieh MH; Shan JC; Huang WL; Cheng WC; Chiu MJ; Jaw FS; Hwu HG; Liu CC
    Schizophr Res; 2012 Sep; 140(1-3):243-9. PubMed ID: 22784684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis.
    Lavoie S; Schäfer MR; Whitford TJ; Benninger F; Feucht M; Klier CM; Yuen HP; Pantelis C; McGorry PD; Amminger GP
    Schizophr Res; 2012 Jul; 138(2-3):206-11. PubMed ID: 22520856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mismatch Negativity reduction in the left cortical regions in first-episode psychosis and in individuals at ultra high-risk for psychosis.
    Solís-Vivanco R; Mondragón-Maya A; León-Ortiz P; Rodríguez-Agudelo Y; Cadenhead KS; de la Fuente-Sandoval C
    Schizophr Res; 2014 Sep; 158(1-3):58-63. PubMed ID: 25064664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontal slow wave resting EEG power is higher in individuals at Ultra High Risk for psychosis than in healthy controls but is not associated with negative symptoms or functioning.
    Sollychin M; Jack BN; Polari A; Ando A; Amminger GP; Markulev C; McGorry PD; Nelson B; Whitford TJ; Yuen HP; Lavoie S
    Schizophr Res; 2019 Jun; 208():293-299. PubMed ID: 30738699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensory gating in subjects at ultra high risk for developing a psychosis before and after a first psychotic episode.
    van Tricht MJ; Nieman DH; Koelman JT; Mensink AJ; Bour LJ; van der Meer JN; van Amelsvoort TA; Linszen DH; de Haan L
    World J Biol Psychiatry; 2015 Jan; 16(1):12-21. PubMed ID: 22730901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cannabis use on event related potentials in subjects at ultra high risk for psychosis and healthy controls.
    van Tricht MJ; Harmsen EC; Koelman JH; Bour LJ; van Amelsvoort TA; Linszen DH; de Haan L; Nieman DH
    Int J Psychophysiol; 2013 May; 88(2):149-56. PubMed ID: 23541998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auditory ERP components before and after transition to a first psychotic episode.
    van Tricht MJ; Nieman DH; Koelman JH; Bour LJ; van der Meer JN; van Amelsvoort TA; Linszen DH; de Haan L
    Biol Psychol; 2011 Jul; 87(3):350-7. PubMed ID: 21536095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automatic auditory processing features in distinct subtypes of patients at clinical high risk for psychosis: Forecasting remission with mismatch negativity.
    Wu G; Tang X; Gan R; Zeng J; Hu Y; Xu L; Wei Y; Tang Y; Chen T; Liu H; Li C; Wang J; Zhang T
    Hum Brain Mapp; 2022 Dec; 43(18):5452-5464. PubMed ID: 35848373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of psychosis by mismatch negativity.
    Bodatsch M; Ruhrmann S; Wagner M; Müller R; Schultze-Lutter F; Frommann I; Brinkmeyer J; Gaebel W; Maier W; Klosterkötter J; Brockhaus-Dumke A
    Biol Psychiatry; 2011 May; 69(10):959-66. PubMed ID: 21167475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex mismatch negativity to tone pair deviants in long-term schizophrenia and in the first-episode schizophrenia spectrum.
    Salisbury DF; McCathern AG; Coffman BA; Murphy TK; Haigh SM
    Schizophr Res; 2018 Jan; 191():18-24. PubMed ID: 28506707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity.
    Perez VB; Woods SW; Roach BJ; Ford JM; McGlashan TH; Srihari VH; Mathalon DH
    Biol Psychiatry; 2014 Mar; 75(6):459-69. PubMed ID: 24050720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.